ArticleTropical medicine and health2026
Epidemiological characteristics of Helicobacter pylori infection in Shizuishan and its association with colorectal cancer and the gut microbiota.
Article in Tropical medicine and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundTo investigate the epidemiological characteristics of Helicobacter pylori (Hp) infection in Shizuishan of Ningxia and to analyze the associations of Hp infection and the gut microbiota with the development of colorectal cancer (CRC).
methodsA cross-sectional study was conducted. From January 2024 to June 2024, 2,000 community residents from 3 areas of Shizuishan City were recruited for Hp screening using the 13C-urea breath test irrespective of digestive symptoms. From this screened community population, 300 healthy controls with normal colonoscopy findings and 100 patients with pathologically confirmed CRC were selected, and stool samples were collected for 16S ribosomal RNA gene sequencing to analyze the gut microbiota. Chi-square test, t test, and multivariable logistic regression were used for statistical analysis.
resultsThe overall Hp positivity rate among screened adults in Shizuishan was 58.4%. The Hp positivity rate in the CRC group (78.0%) was significantly higher than that in the healthy control group (52.3%) (P < 0.001). After adjustment for age, sex, body mass index (BMI), smoking history, and drinking history, Hp infection remained an independent risk factor for CRC (odds ratio (OR) = 2.15, 95% confidence interval (95% CI) 1.42-3.28). Gut microbiota analysis showed that alpha diversity (Shannon index) in the CRC group was significantly lower than that in the healthy control group (P < 0.001) and in the Hp-positive healthy subgroup (P < 0.05). Beta-diversity analysis showed significant separation in microbial community structure among the three groups (Adonis, P < 0.001). Linear discriminant analysis effect size analysis showed enrichment of pathogenic bacteria such as Fusobacterium nucleatum and Escherichia coli in the CRC group, whereas beneficial bacteria that produce short-chain fatty acids, such as Roseburia and Faecalibacterium prausnitzii, were reduced. The microbial community structure of Hp-positive healthy individuals had shown a transitional state between that of Hp-negative healthy individuals and CRC patients.
conclusionsThe Hp positivity rate among screened community residents was relatively high in Shizuishan, and Hp infection is an independent risk factor for CRC. Hp infection may increase the risk of CRC by disrupting gut microbiota homeostasis and promoting the formation of a pro-carcinogenic microbial community.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.